julie fisher from georgetown university medical center joining us there from alexandria virginia. thank you for your time. thank you so much. still ahead on al jazeera is going concern about anti vaccine protests and who's organizing them. and we look at some of the proposals chili's assembly. we'll have to consider as it rewrites the competition. ah, ah, look forward to brita sky's with sponsored point cutaways. hey there, you're locked in to your weather update for asia. good to see you will begin in the subcontinent. were a poor air quality toward the northeast of pakistan. the northwest of india, new delhi has a high of 22 degrees. ne monsoon. not active right now. so that means dry spells pretty much for that. se corner rate through sri lanka and the mall dees. i think the only spot really we'll see some activity is for the far northeast of india around the border with bungler dash, but nothing major here. next, stop se asia for indonesia is islands in the zone here. we've seen about 60 to 75 millimeters of rain. i think we will see some similar balance for the southern phili

fischer is an associate research profession professor of micro biology and immunology at georgetown university medical center. she says, regulators will have to weigh at the risk of infection for younger children against the results of clinical trials. while children have have been shown to be at lower risk of developing severe disease than older adults, most certainly, they are still vulnerable to infection. and during the search of the omicron variant in the past month, in the u. s. rates of hospitalization for the youngest children under 5 years of age search. and they were, they were 3 times higher than rates in older children who are eligible for vaccination. so why that lower risk? it's certainly not, not negligible. the clinical trials are not on enormous numbers of kids. i think the number was about 1700 kids. so they, the doses have been shown to be safe that the dose of thing kill them to 2 small children is much smaller than the adult. those about the 10th of the dose that adults and teens get the, the size of the clinical trial is very carefully constructed, to be able to look at potential side e